OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Relugolix in the management of prostate cancer
Kamal Kant Sahu, Nishita Tripathi, Neeraj Agarwal, et al.
Expert Review of Anticancer Therapy (2022) Vol. 22, Iss. 9, pp. 891-902
Closed Access | Times Cited: 6
Kamal Kant Sahu, Nishita Tripathi, Neeraj Agarwal, et al.
Expert Review of Anticancer Therapy (2022) Vol. 22, Iss. 9, pp. 891-902
Closed Access | Times Cited: 6
Showing 6 citing articles:
Solid Self-Microemulsifying Drug Delivery System for Improved Oral Bioavailability of Relugolix: Preparation and Evaluation
Zilin Li, Guo-Xing Deng, Chao Fang, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 1065-1082
Open Access
Zilin Li, Guo-Xing Deng, Chao Fang, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 1065-1082
Open Access
Safety and Tolerability of Relugolix in Combination with Abiraterone or Apalutamide for Treatment of Patients with Advanced Prostate Cancer: Data from a 52-Week Clinical Trial
Jose De La Cerda, Laurence Belkoff, Kevin D. Courtney, et al.
Targeted Oncology (2025)
Open Access
Jose De La Cerda, Laurence Belkoff, Kevin D. Courtney, et al.
Targeted Oncology (2025)
Open Access
Review of drug-drug interactions in patients with prostate cancer
Andrew Ruplin, Eve M. Segal, Thomas McFarlane
Journal of Oncology Pharmacy Practice (2024) Vol. 30, Iss. 6, pp. 1057-1072
Open Access | Times Cited: 3
Andrew Ruplin, Eve M. Segal, Thomas McFarlane
Journal of Oncology Pharmacy Practice (2024) Vol. 30, Iss. 6, pp. 1057-1072
Open Access | Times Cited: 3
Profile of Relugolix in the Management of Advanced Hormone-Sensitive Prostate Cancer: Design, Development, and Place in Therapy
Tomoyuki Tatenuma, Hiroshi Miyamoto
Drug Design Development and Therapy (2023) Vol. Volume 17, pp. 2325-2333
Open Access | Times Cited: 4
Tomoyuki Tatenuma, Hiroshi Miyamoto
Drug Design Development and Therapy (2023) Vol. Volume 17, pp. 2325-2333
Open Access | Times Cited: 4
Post-marketing safety concerns with relugolix: a disproportionality analysis of the FDA adverse event reporting system
C. Xia, Zhijing Liu, Jie Liu, et al.
Investigational New Drugs (2024) Vol. 42, Iss. 5, pp. 500-509
Closed Access
C. Xia, Zhijing Liu, Jie Liu, et al.
Investigational New Drugs (2024) Vol. 42, Iss. 5, pp. 500-509
Closed Access
THE ROLE OF THE ANDROGEN RECEPTOR IN PROSTATE CANCER
Anna Barnaś, Andrzej Antczak, Wojciech A. Cieślikowski
Postępy Biologii Komórki (2023) Vol. 50, Iss. 1, pp. 19-26
Open Access
Anna Barnaś, Andrzej Antczak, Wojciech A. Cieślikowski
Postępy Biologii Komórki (2023) Vol. 50, Iss. 1, pp. 19-26
Open Access
